Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. [electronic resource]
Producer: 20060829Description: 712-8 p. digitalISSN:- 1083-8791
- Adult
- Alemtuzumab
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm -- administration & dosage
- Antilymphocyte Serum -- therapeutic use
- Busulfan -- administration & dosage
- Child
- Child, Preschool
- Cyclophosphamide -- therapeutic use
- Fanconi Anemia -- therapy
- Female
- Graft vs Host Disease -- etiology
- Hematopoietic Stem Cell Transplantation -- methods
- Histocompatibility Testing
- Humans
- Immunosuppressive Agents -- therapeutic use
- Male
- Myeloablative Agonists -- therapeutic use
- Transplantation Conditioning -- methods
- Treatment Outcome
- Vidarabine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.